CPhI Online

Robust by design – How BD is overcoming the biologics challenge in drug delivery

18 Sep 2020

This article explores how BD is dedicated to deliver best-in-class product performance and services by applying the latest advances in drug delivery technology.

Becton, Dickinson and Company (BD) is developing a 2.25 mL dose volume fully integrated autoinjector with BD Neopak™ XtraFlow™ – BD’s latest prefillable glass-based syringe system featuring an 8 mm needle with ultra-thin wall cannula technology. BD has designed autoinjectors that can deliver drugs of differing viscosities in a well-integrated robust system. Pharmaceutical companies can adapt BD Intevia™ to deliver a range of drug volumes and viscosities without any need for customisation of the system or its components.

Read More